Indian Journal of Medical and Paediatric Oncology, Table of Contents CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2020; 41(04): 550-551DOI: 10.4103/ijmpo.ijmpo_61_20 Traineeʼs Corner Pharmacogenomics M Shivashankara Department of Medical Oncology, Army Hospital Research and Referral, New Delhi, India › Author AffiliationsRecommend Article Abstract Full Text References References 1 Albertini L, Siest G, Jeannesson E, Visvikis-Siest S. Availability of pharmacogenetic and pharmacogenomic information in anticancer drug monographs in France: Personalized cancer therapy. Pharmacogenomics 2011; 12: 681-91 2 Relling MV, Gardner EE, Sandborn WJ, Schmiegelow K, Pui CH, Yee SW. et al. Clinical pharmacogenetics implementation consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing. Clin Pharmacol Ther 2011; 89: 387-91 3 Coriat R, Chaussade S. Pro or con the phenotyping/genotyping of patients treated by 5-fluorouracil to prevent adverse drug reactions?. Therapie 2007; 62: 105-9 4 Innocenti F, Undevia SD, Iyer L, Chen PX, Das S, Kocherginsky M. et al. Genetic variants in the UDP-glucuronosyltransferase 1A1 gene predict the risk of severe neutropenia of irinotecan. J Clin Oncol 2004; 22: 1382-8
